Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-27 to 2024-07-19
Current total value of award: $18834.53
Description: 4565057925!XOLAIR 300 MG/2 ML AUTOINJECT 2ML